| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 05/14/2009 | WO2009061314A1 Hole transport polymer for use in electronic devices |
| 05/14/2009 | WO2009061145A1 New compound and organic light emitting device using the same |
| 05/14/2009 | WO2009060780A1 Organic electroluminescence element, display device, and lighting system |
| 05/14/2009 | WO2009060779A1 Organic electroluminescent device material, organic electroluminescent device, display device and illuminating device |
| 05/14/2009 | WO2009060757A1 Organic electroluminescent device, display device and illuminating device |
| 05/14/2009 | WO2009042632A3 Combination therapy related to serotonin dual action compounds |
| 05/14/2009 | WO2009019561A3 Process for preparing chiral compounds |
| 05/14/2009 | US20090124792 Fluorescent polymethine cyanine dyes |
| 05/14/2009 | US20090124682 Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity |
| 05/14/2009 | US20090124651 Catecholamine derivatives and prodrugs thereof |
| 05/14/2009 | US20090124620 Plasminogen activator inhibitor-1 inhibitor |
| 05/14/2009 | US20090124616 7-nonsubstituted indole mcl-1 inhibitors |
| 05/14/2009 | US20090124598 Pharmaceutical use of substituted amides |
| 05/14/2009 | US20090123555 Stimulateable Polymer Particles Exhibiting Reactive Functions, Method for the Production and the Use Thereof |
| 05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
| 05/14/2009 | DE60226044T2 Kristalline formen von fluvastatin-natrium Crystalline form of fluvastatin sodium |
| 05/13/2009 | EP2057139A1 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| 05/13/2009 | EP2057119A1 3- (ih-indol- 3-ydindan-1-ylamine derivatives for the treatment of depression and anxiety |
| 05/13/2009 | EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1678135B1 Process for the preparation of n-amino substituted heterocyclic compounds |
| 05/13/2009 | EP1565429B1 Diaryl ureido derivatives and their medical use |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | CN101432266A Production process for bicyclic tetrahydropyrrole compounds |
| 05/13/2009 | CN101432265A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432264A Salts with CRTH2 antagonist activity |
| 05/13/2009 | CN101432259A Anthracene derivative, and light-emitting element, light-emitting device, electronic device using anthracene derivative |
| 05/13/2009 | CN101429156A Novel methods for producing 1,2,3,4-tetrahydrochysene-4,4-dimethyl quinoline and its derivant |
| 05/13/2009 | CN100486982C Compound possessing function for preventing and curing thrombus disease, its pharmacy composition and usage in medication |
| 05/13/2009 | CN100486981C Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science |
| 05/13/2009 | CN100486977C Novel preparation method of ramosetron hydrochloride |
| 05/13/2009 | CN100486966C Near infrared fluorescent probe for detecting hydroxyl free radicals, synthesis method and use thereof |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/12/2009 | US7531672 Preparation of heterocyclic ketones |
| 05/12/2009 | US7531671 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/12/2009 | US7531670 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 05/12/2009 | US7531668 2-arylcarboxamide-nitrogenous heterocycle compound |
| 05/12/2009 | US7531665 Kinase inhibitors for the treatment of disease |
| 05/12/2009 | US7531569 Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | CA2261453C Process for the preparation of an optically active indoline-2-carboxylic acid or derivative thereof |
| 05/07/2009 | WO2009058051A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof |
| 05/07/2009 | WO2009056707A2 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/07/2009 | WO2009023160A3 Novel inhibitors of bacterial sortase enzymes and methods of using the same |
| 05/07/2009 | WO2007085933A3 Process for the preparation of n-[1-(s)-ethoxycarbonyl-1-butyl]-(s)-alanine-dmt complex and its use in the preparation of perindopril |
| 05/07/2009 | US20090118519 Production Method of Polycyclic Lactams |
| 05/07/2009 | US20090118518 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 05/07/2009 | US20090118503 Faah inhibitors |
| 05/07/2009 | US20090118351 Angiotensin I-Converting Enzyme (ACE) Inhibitors |
| 05/07/2009 | US20090118350 Biomarkers for Identifying Efficacy of Tegaserod in Patients with Chronic Constipation |
| 05/07/2009 | US20090118323 Antitumor benzoylsulfonamides |
| 05/07/2009 | US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117042 Imaging agents and methods of imaging NAALADase or PSMA |
| 05/07/2009 | CA2696237A1 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/06/2009 | EP2054384A1 Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| 05/06/2009 | EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/06/2009 | EP2054055A2 Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent |
| 05/06/2009 | EP1725632A4 New materials for injecting or transporting holes and organic electroluminescence devices using the same |
| 05/06/2009 | EP1667678B1 Animal feed composition |
| 05/06/2009 | EP1569902B1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 05/06/2009 | EP1268421B1 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 05/06/2009 | EP1242082B1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/06/2009 | CN101426771A Process for manufacturing diazepine derivatives |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423610A Novel phenylacetylene end capacity capped polyimide prepolymer and preparation method thereof |
| 05/06/2009 | CN101423491A Acenaphtho-heterocycles compounds and application thereof in preparation of BH3 analogue Bcl-2 family protein inhibitor |
| 05/06/2009 | CN101423490A Synthetic method of Trandolapril key intermediate (2S,3aR,7as)-octahydro-1H-indole-2-carboxylic acid |
| 05/06/2009 | CN101423489A Indoline-2-one derivates and uses thereof |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN100486030C Electrolytic solution and battery |
| 05/06/2009 | CN100484922C Process for preparing biphthalimide |
| 05/06/2009 | CN100484921C Synthesis of 3-hydroxyphthalimidine derivative |
| 05/05/2009 | US7528263 Oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and related compounds |
| 05/05/2009 | US7528262 {1-[4-(3-Pyrrolidin-1-ylpropoxy)phenyl]-1H-indol-2-yl}methanol; inflammation, migraine, motion sickness, pain, Parkinson's Disease, epilepsy, cardiovascular disease (i.e. hyper or hypotension, acute myocardial infarction), gastrointestinal disorders; cognitive disorders |
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 05/05/2009 | US7528165 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure |
| 05/05/2009 | US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7528120 phosphoric acid mono-[2-hydroxymethyl-4-(4-octyl-phenyl)-2-(1-oxo-1,3-dihydro-isoindol-2-yl)-butyl] ester; disorders mediated by lymphocytes interactions like transplant rejection, graft versus host disease, autoimmune diseases; binding affinity to Sphingosine-1-phosphate(S1P) receptors |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009055519A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009055516A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009054793A1 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054791A1 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054653A2 Isoindolones with high binding affinity to beta-amyloid aggregates and fibrils, and its use and preparation method |
| 04/30/2009 | WO2009054531A1 Liquid crystal aligning agent, method for forming liquid crystal alignment film, and liquid crystal display device |
| 04/30/2009 | WO2009054401A1 Anti-viral agent comprising heterocyclic aromatic compound as active ingredient |
| 04/30/2009 | WO2009054202A1 Process for producing organic compound and organic compound obtained by the same |
| 04/30/2009 | WO2009053997A1 Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
| 04/30/2009 | WO2009053754A2 Novel crystalline forms |
| 04/30/2009 | WO2009053750A2 Novel crystalline and amorphous forms |
| 04/30/2009 | WO2009053733A2 Novel crystalline forms |
| 04/30/2009 | WO2009053732A1 Novel salt |
| 04/30/2009 | WO2009053440A1 Indoline compounds |
| 04/30/2009 | WO2009033033A3 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases |
| 04/30/2009 | US20090111999 Process for producing an aromatic unsaturated compound |